Economy

Cautious China approves GMO alfalfa imports in goodwill gesture to US

REUTERS

CHINA approved imports of eight genetically modified organism (GMO) crops, permitting shipments of GM alfalfa for the first time after a decade-long wait, the agriculture ministry said.

Global seed makers and the US government welcomed the decision after Beijing’s slow approval process disrupted grain exports and launches of crops that need clearance from China because it is one of the world’s biggest agriculture markets.

The approvals are “a positive step towards resolving the longstanding challenges biotechnology developers face in obtaining import approvals in China,” said the Biotechnology Innovation Organization in Washington, the world’s largest trade association for biotech companies like Bayer AG.

Beijing has a cautious approach to GM technology and has not approved any major food crops for cultivation, despite President Xi Jinping’s backing of the technology.

China allows the import of GM crops used in animal feed, but trade partners say the process is not always based on science and is often driven by politics.

Among those approved were two glyphosate-resistant types of alfalfa first submitted for approval more than 10 years ago. The crops are owned by Land O’Lakes subsidiary Forage Genetics International, after being co-developed by the company and Monsanto, now owned by Bayer, said Glenda Gehl, Forage Genetics’ vice-president and general manager.

US farmers already grow the alfalfa, but Beijing’s approvals open the door for expanded plantings in Western states that supply export markets, she said.

“This is a huge opportunity for alfalfa growers across the US,” Ms. Gehl said.

Access to biotechnology is especially important because of heightened concerns about global food security and high commodity prices, said Alexis Taylor, a US Department of Agriculture undersecretary, in an e-mail to Reuters.

China also approved a Corteva, Inc. glyphosate-resistant canola, DP73496, first developed by DuPont Pioneer and submitted for approval in July 2012. Corteva plans to launch its Optimum GLY canola hybrids in North America and Australia, and is still pursuing other import approvals, said spokesperson Kris Allen.

Beijing promised to speed up access to its market under the Phase 1 trade deal concluded with the United States in 2020. The approvals come after the first meeting between US President Joe Biden and China’s Xi in November amid efforts to repair tense relations.

China could use the approvals as a goodwill gesture and as justification for a potential decision to cultivate more GM crops domestically, said John Baize, president of US consultancy John C. Baize & Associates.

“They can say to the US: ‘See, you wanted us to speed up our approval. We did,’” Mr. Baize said.

China also cleared two GM sugar cane traits developed in Brazil, along with a BASF SE herbicide-resistant cotton. The crops were allowed to be imported for processing in China from Jan. 5 for the next five years.

China also approved the safety of three domestically developed GM products, including insect- and glyphosate-resistant corn from Yuan Longping High-tech Agriculture Ltd. and Hangzhou Ruifeng’s insect-resistant soybean. — Reuters 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Your daily news source covering investing ideas, market stocks, business, retirement tips from Wall St. to Silicon Valley.

Disclaimer:

TheProficientInvestor.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 TheProficientInvestor. All Rights Reserved.

To Top